Ibrutinib Chronic lymphocytic leukemia with 17p deletion medicine
02/02/2022 Alternative Treatments
Price: Check with seller
Description
Ibrutinib is a kinase inhibitor drug that inhibits BTK enzymatic activity. BTK is a B-cell antigen receptor (BCR) and cytokine receptor pathways signaling molecule. This drug is used in the treatment of patients with Chronic lymphocytic leukemia with 17p deletion, Chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström’s macroglobulinemia. Ibrutinib comes in tablets at 140 mg to administer orally.
Ibrutinib capsules 140 mg price in India is pocket-friendly; it is readily available with many generic medicine suppliers. To buy this medicine, ring 18008891064.
Comments
annie pery
Individual
More Details